Last reviewed · How we verify
Congenital hyperinsulinism
Approved treatments
- Sandostatin · Novartis
Sandostatin works by mimicking the natural hormone somatostatin to inhibit the release of various hormones and growth factors.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Congenital hyperinsulinism patent landscape — cliff calendar, originator estates, attackable patents
- Congenital hyperinsulinism treatment landscape brief
- Congenital hyperinsulinism treatment updates RSS
Frequently asked questions about Congenital hyperinsulinism
What drugs treat Congenital hyperinsulinism?
Tracked treatments include Sandostatin.
What is the treatment for Congenital hyperinsulinism?
Standard treatment for Congenital hyperinsulinism includes Sandostatin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Congenital hyperinsulinism patent cliff · Congenital hyperinsulinism CI report
- Treatment: Sandostatin · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing